Northlight Capital Partners and Condor Partners Announce Refinancing & Future Funding for Mural Park
This redevelopment project has transformed two historic industrial buildings into modern, Class A brick-and-timber loft office buildings designed for today's modern tenants.
"Beginning in 2024, Northlight began looking at the office credit market as a compelling special situation investment opportunity," said Ben Gerig, Chief Executive Officer of Northlight Capital Partners. "We are excited to work with Condor and look forward to bringing capital to Mural Park as they continue to execute on their business plan and lease up strategy."
Mural Park is located in Chicago's historic Pilsen neighborhood – named one of the world's 12 coolest neighborhoods by Forbes in 2019. This redevelopment project has transformed two historic industrial buildings into modern, Class A brick-and-timber loft office buildings designed for today's modern tenants. Since opening in 2019, Mural Park has leased 150,000 square feet of office space, including over 130,000 square feet since the onset of the COVID-19 pandemic. Tenants include HCSC (Blue Cross Blue Shield Parent), One Hope United, Noble Charter Schools, Relay Graduate School of Education, Puratos, OneSix Solutions, Eversight, and 5 Rabbit Cerveceria.
'The genesis of this project was anchored in community engagement, public benefit, and a commitment to positive, regenerative impact,' said Michael McLean Jr, Partner at Condor Partners. 'The result is a resilient and successful project that continues to defy the market and attract tenants. We greatly appreciate Northlight's ability to look past the noise and recognize the unique way Condor approaches development. Our investment in communities shifts the dynamics, and ultimately delivers stronger, more meaningful results.'
Mural Park recently welcomed One Hope United, a nonprofit organization serving over 10,000 children and families annually across Illinois and Florida, with more than 800 employees and 9 locations. The organization took possession of 14,000 square feet of custom-built space in March, bringing the project to 75% leased and occupied. Additionally, 5 Rabbit Cerveceria is now under construction of a 12,000sf restaurant and mircrobrewery after years of pandemic-related delays. 'We are excited to reintroduce Mural Park to tenants seeking standout office space in Chicago,' said Konstantine Sepsis, Avison Young. 'Its continued leasing, even through challenging times, is a testament to the truly special nature of this project.'
About Northlight Capital Partners, LLC
Northlight Capital Partners, LLC ('NCP') is a middle-market real estate credit specialist and fund manager headquartered in Westport, CT. The company manages capital on behalf of various institutional, endowment and family office clients. Since 2011, NCP has managed and advised on investment vehicles totaling more than $500 million of capital, originating special situation debt and preferred equity and acquiring sub and non-performing loans. For more information, please visit https://nlightcp.com.
About Condor Partners
Condor Partners, a boutique development firm with over 100 years of combined experience, goes beyond creating structures. We're passionate about building vibrant communities. We seek unique opportunities to uplift neighborhoods, ethically revitalizing existing landscapes while pioneering new and innovative ones. For more information, please visit www.condorpartners.net.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Why Is Wall Street So Bearish on Lululemon? There's 1 Key Reason.
Key Points Two major trends haven't done the athleisurewear company any favors recently. One worrying development from this is a significant erosion in top-line growth. 10 stocks we like better than Lululemon Athletica Inc. › Lululemon Athletica (NASDAQ: LULU) stock has looked very drained and low-energy in recent months. The athletic apparel specialist's share price trades nearly 47% year to date, while the benchmark S&P 500 index is up by almost 10%. It wasn't so long ago that Lululemon was a star in the always tough and highly competitive specialty clothing industry. A closer look at how it started falling from the sky, and whether it's got a chance at regaining altitude, will show the main reason for its drop. Stiff headwinds Basically, Lululemon has struggled to cope with two trends -- rising competition, and the end of the COVID-19 pandemic-era boom in exercise products, services, and apparel. With the many closures and lock-ins of that age, people were often stuck for things to do. Two activities that could be conducted at home with relative safety were working out or doing yoga, hence the rise in demand for athleisurewear. This coincided with the rise of Lululemon as a brand; the company had clothes and accessories that not only looked good but were highly practical for such pursuits. Excessive success leads to determined competition, and rivals inevitably piled into the space. At the same time, the company was maturing, a combination that slowed sales growth notably. From a 42% improvement in fiscal 2021, in the three subsequent years, growth withered to 30%, 19%, and finally 10% in 2024. To its credit, Lululemon has been able to consistently land in positive territory on the bottom line. But investors are always hungry for meaningful revenue growth, and when that slows, they often bail. One brand among many To its credit, Lululemon has remained profitable, as it's continued to -- sensibly, in my view -- focus on that combination of product style, durability, and usefulness. Yet with those determined competitors crowding its space, the company's wares aren't as distinctive as they used to be. Given that, I'd probably be hesitant to buy the stock for its growth potential until the company figures out how to better distinguish itself in the market again. Should you buy stock in Lululemon Athletica Inc. right now? Before you buy stock in Lululemon Athletica Inc., consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Lululemon Athletica Inc. wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,076,588!* Now, it's worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lululemon Athletica Inc. The Motley Fool has a disclosure policy. Why Is Wall Street So Bearish on Lululemon? There's 1 Key Reason. was originally published by The Motley Fool
Geek Wire
2 minutes ago
- Geek Wire
TeamSense, a Seattle-area startup that helps track employee absences, raises more cash
GeekWire's startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter , and check out the GeekWire funding tracker and venture capital directory . TeamSense CEO Sheila Stafford. (LinkedIn Photo) Seattle-area startup TeamSense, a software platform used by employers for absence reporting and employee communications, is raising fresh investment. The company recently raised $19.5 million, according to a new filing with the SEC. TeamSense CEO Sheila Stafford declined to comment when reached by GeekWire. TeamSense originally spun out of a joint innovation studio managed by Seattle-based Pioneer Square Labs and Fortive, the Everett, Wash.-based industrial giant. The company launched in 2020 and built software to help employers track COVID-19 symptoms at the workplace. The product has evolved into a text-based system designed to manage employee attendance in real-time. Employees can use TeamSense to tell employers when they can't come to work. Managers are notified immediately and the data is tracked for HR teams. The software uses automatic language translation and integrates with other HR platforms such as Workday, Zenefits, ADP, and more. TeamSense's customers include manufacturing and logistics companies. The startup has around 30 employees, according to LinkedIn. Fortive acquired TeamSense in 2021. The company has operated independently since 2022; Fortive remains a minority investor. TeamSense raised $4 million in 2023 from Bonfire Ventures and Operator Collective. Stafford previously held leadership roles at Fluke, Whirlpool, and GM.
Yahoo
an hour ago
- Yahoo
Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership
Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company's non-mRNA COVID-19 vaccine is approved, strengthening its Sanofi partnership. A closeup of a vial of the biotechnology company's vaccines. Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and Matrix-M adjuvant technology. The Maryland-based company has an approved COVID-19 vaccine, Nuvaxovid, which is being commercialized globally through partnerships, including a major agreement with Sanofi. Currently, the company is expanding its product reach for emerging infectious disease prevention. On May 19, 2025, Novavax, Inc. (NASDAQ:NVAX) announced that it had received U.S. FDA Biologics License Application (BLA) approval for Nuvaxovid™, a recombinant protein-based, non-mRNA COVID-19 vaccine. The BLA approval triggered a $175 million milestone payment from Sanofi. Later, for select markets, Novavax, Inc. (NASDAQ:NVAX) has completed the transition of Nuvaxovid™ commercial leadership to Sanofi for the 2025-2026 COVID-19 vaccination season. By Q4 2025, the marketing authorization transfers to Sanofi for the U.S. and EU markets will be completed, which will result in an additional $50 million in combined milestones. Additionally, in June 2025, initial cohort data from a Phase 3 trial for Novavax's COVID-19-Influenza-Combination (CIC) and stand-alone influenza vaccine candidates showed significant immune responses, with T-cell responses numerically higher than the comparator Fluzone HD arm. With the results suggesting increased duration of protection, the company is discussing potential partnerships for these late-stage assets. Novavax, Inc. (NASDAQ:NVAX)'s 29.12% short float signals heavy bearish sentiment. With it, the company is up on the stage for a sharp rebound with slight positive market sentiment shifts. While we acknowledge the potential of NVAX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best REIT Stocks to Buy Right Now and 10 Stocks with Huge Catalysts on the Horizon Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
